Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Hochegger, K; Rudnicki, M; Auinger, M; Mark, W; Margreiter, R; Mayer, G; Rosenkranz, AR.
Fever of unknown origin in renal transplant patients with tacrolimus.
Clin Transplant. 2009; 23(4):575-579
Doi: 10.1111/j.1399-0012.2008.00941.x
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Eller Kathrin
- Rosenkranz Alexander
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The immunosuppressive agent tacrolimus is now widely used for the prevention of acute and chronic rejection in renal allograft recipients. We here report on three patients, who developed drug-induced fever due to tacrolimus one to five months after renal transplantation. Extensive search for a focus, autoantibodies and virus infection remained inconclusive. Therefore, drug-induced fever was suggested. After discontinuing tacrolimus and switching to cyclosporine A fever completely resolved within 24 h. This report demonstrates that tacrolimus-induced drug fever should be included in the differential diagnosis of fever of unknown origin in renal transplant recipients.
- Find related publications in this database (using NLM MeSH Indexing)
- Adolescent -
- Adult -
- C-Reactive Protein - analysis
- Female -
- Fever - chemically induced
- Humans -
- Immunosuppressive Agents - adverse effects
- Kidney Transplantation - adverse effects
- Male -
- Middle Aged -
- Pancreas Transplantation -
- Tacrolimus - adverse effects
- Find related publications in this database (Keywords)
- drug-fever
- FK506
- immunosuppression